Literature DB >> 25301983

Synthesis and heating effect of iron/iron oxide composite and iron oxide nanoparticles.

Q Zeng1, I Baker1, J A Loudis1, Y F Liao1, P J Hoopes2.   

Abstract

Fe/Fe oxide nanoparticles, in which the core consists of metallic Fe and the shell is composed of Fe oxides, were obtained by reduction of an aqueous solution of FeCl3 within a NaBH4 solution, or, using a water-in-oil micro-emulsion with CTAB as the surfactant. The reduction was performed either in an inert atmosphere or in air, and passivation with air was performed to produce the Fe/Fe3O4 core/shell composite. Phase identification and particle size were determined by X-ray diffraction and TEM. Thermal analysis was performed using a differential scanning calorimeter. The quasistatic magnetic properties were measured using a VSM, and the specific absorption rates (SARs) of both Fe oxide and Fe/Fe3O4 composite nanoparticles either dispersed in methanol or in an epoxy resin were measured by Luxtron fiber temperature sensors in an alternating magnetic field of 150 Oe at 250 kHz. It was found that the preparation conditions, including the concentrations of solutions, the mixing procedure and the heat treatment, influence the particle size, the crystal structure and consequently the magnetic properties of the particles. Compared with Fe oxides, the saturation magnetization (MS ) of Fe/Fe3O4 particles (100-190 emu/g) can be twice as high, and the coercivity (HC ) can be tunable from several Oe to several hundred Oe. Hence, the SAR of Fe/Fe3O4 composite nanoparticles can be much higher than that of Fe oxides, with a maximum SAR of 345 W/g. The heating behavior is related to the magnetic behavior of the nanoparticles.

Entities:  

Keywords:  Fe nanoparticles; SAR; chemical reduction; hyperthermia; magnetic nanoparticles

Year:  2007        PMID: 25301983      PMCID: PMC4187116          DOI: 10.1117/12.708182

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  4 in total

1.  Selective inductive heating of lymph nodes.

Authors:  R K GILCHRIST; R MEDAL; W D SHOREY; R C HANSELMAN; J C PARROTT; C B TAYLOR
Journal:  Ann Surg       Date:  1957-10       Impact factor: 12.969

2.  Magnetic properties of ultrafine iron particles.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1992-05-01

3.  Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer.

Authors:  Robert Ivkov; Sally J DeNardo; Wolfgang Daum; Allan R Foreman; Robert C Goldstein; Valentin S Nemkov; Gerald L DeNardo
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

4.  Functional magnetic particles for medical application.

Authors:  Masashige Shinkai
Journal:  J Biosci Bioeng       Date:  2002       Impact factor: 2.894

  4 in total
  4 in total

1.  Surface Engineering of Core/Shell Iron/Iron Oxide Nanoparticles from Microemulsions for Hyperthermia.

Authors:  Guandong Zhang; Yifeng Liao; Ian Baker
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2010-01-01       Impact factor: 7.328

2.  The Dartmouth Center for Cancer Nanotechnology Excellence: magnetic hyperthermia.

Authors:  Ian Baker; Steve N Fiering; Karl E Griswold; P Jack Hoopes; Katerina Kekalo; Christian Ndong; Keith Paulsen; Alicea A Petryk; Brian Pogue; Fridon Shubitidze; John Weaver
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

3.  Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications.

Authors:  Dmitri Lapotko
Journal:  Nanomedicine (Lond)       Date:  2009-10       Impact factor: 5.307

4.  Albumin Stabilized Fe@C Core-Shell Nanoparticles as Candidates for Magnetic Hyperthermia Therapy.

Authors:  Maria Antonieta Ramírez-Morales; Anastasia E Goldt; Polina M Kalachikova; Javier A Ramirez B; Masashi Suzuki; Alexey N Zhigach; Asma Ben Salah; Liliya I Shurygina; Sergey D Shandakov; Timofei Zatsepin; Dmitry V Krasnikov; Toru Maekawa; Evgeny N Nikolaev; Albert G Nasibulin
Journal:  Nanomaterials (Basel)       Date:  2022-08-20       Impact factor: 5.719

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.